336 related articles for article (PubMed ID: 20410195)
1. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.
Weinstein RS; Jilka RL; Almeida M; Roberson PK; Manolagas SC
Endocrinology; 2010 Jun; 151(6):2641-9. PubMed ID: 20410195
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice.
Weinstein RS; O'Brien CA; Almeida M; Zhao H; Roberson PK; Jilka RL; Manolagas SC
Endocrinology; 2011 Sep; 152(9):3323-31. PubMed ID: 21771887
[TBL] [Abstract][Full Text] [Related]
3. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.
Plotkin LI; Bivi N; Bellido T
Bone; 2011 Jul; 49(1):122-7. PubMed ID: 20736091
[TBL] [Abstract][Full Text] [Related]
4. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength.
O'Brien CA; Jia D; Plotkin LI; Bellido T; Powers CC; Stewart SA; Manolagas SC; Weinstein RS
Endocrinology; 2004 Apr; 145(4):1835-41. PubMed ID: 14691012
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.
Weinstein RS; Jilka RL; Parfitt AM; Manolagas SC
J Clin Invest; 1998 Jul; 102(2):274-82. PubMed ID: 9664068
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization.
Yao W; Cheng Z; Pham A; Busse C; Zimmermann EA; Ritchie RO; Lane NE
Arthritis Rheum; 2008 Nov; 58(11):3485-97. PubMed ID: 18975341
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.
Jia D; O'Brien CA; Stewart SA; Manolagas SC; Weinstein RS
Endocrinology; 2006 Dec; 147(12):5592-9. PubMed ID: 16935844
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone signaling in mature osteoblasts/osteocytes protects mice from age-related bone loss.
Uda Y; Saini V; Petty CA; Alshehri M; Shi C; Spatz JM; Santos R; Newell CM; Huang TY; Kochen A; Kim JW; Constantinou CK; Saito H; Held KD; Hesse E; Pajevic PD
Aging (Albany NY); 2021 Dec; 13(24):25607-25642. PubMed ID: 34968192
[TBL] [Abstract][Full Text] [Related]
10. Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration.
Jilka RL; Almeida M; Ambrogini E; Han L; Roberson PK; Weinstein RS; Manolagas SC
Aging Cell; 2010 Oct; 9(5):851-67. PubMed ID: 20698835
[TBL] [Abstract][Full Text] [Related]
11. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
[TBL] [Abstract][Full Text] [Related]
12. [Glucocorticoid and Bone. The effect of glucocorticoid and PTH in osteoblast apoptosis and differentiation via interleukin 11 expression].
Endo I
Clin Calcium; 2014 Sep; 24(9):1321-8. PubMed ID: 25177004
[TBL] [Abstract][Full Text] [Related]
13. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
14. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
[TBL] [Abstract][Full Text] [Related]
15. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts.
Jilka RL; O'Brien CA; Ali AA; Roberson PK; Weinstein RS; Manolagas SC
Bone; 2009 Feb; 44(2):275-86. PubMed ID: 19010455
[TBL] [Abstract][Full Text] [Related]
16. The skeletal effects of glucocorticoid excess override those of orchidectomy in mice.
Weinstein RS; Jia D; Powers CC; Stewart SA; Jilka RL; Parfitt AM; Manolagas SC
Endocrinology; 2004 Apr; 145(4):1980-7. PubMed ID: 14715712
[TBL] [Abstract][Full Text] [Related]
17. Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.
Bellido T; Plotkin LI
Bone; 2011 Jul; 49(1):50-5. PubMed ID: 20727997
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
[TBL] [Abstract][Full Text] [Related]
19. [Differential effects on bone and mesenchymal stem cells caused by intermittent and continuous PTH administration].
Zhang LX; Balani YM; Trinh S; Kronenberg HM; Mu Y
Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(10):781-787. PubMed ID: 29562406
[No Abstract] [Full Text] [Related]
20. [Glucocorticoid and Bone. The inhibition of osteoblast differentiation and induction of osteocyte apoptosis through the regulation of Bcl-2 by glucocorticoids].
Moriishi T; Komori T
Clin Calcium; 2014 Sep; 24(9):1329-36. PubMed ID: 25177005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
